Anticancer Drugs
HealthBy Luke Andrews2023-03-24 15:54:20
An experimental pill for leukemia has shown promise in early clinical trials sending a third of patients with aggressive disease into complete remission. The...
HealthPress Release2023-03-24 12:00:00
WOODINVILLE, Wash. and SUZHOU, China, March 24, 2023 /PRNewswire/ -- ProfoundBio, a clinical stage biotechnology company focused on the development of novel...
HealthPress Release2023-03-24 14:01:00
SILVER SPRING, Md., March 24, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued draft guidance, Clinical Trial Considerations to...
HealthPress Release2023-03-25 02:00:00
DUBLIN, March 24, 2023 /PRNewswire/ -- The "Pancreatic Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering....
Business / FinancePress Release2023-03-24 13:00:00
FN Media Group Presents USA News Group News Commentary VANCOUVER, British Columbia, March 24, 2023 /PRNewswire/ -- USA News Group - Treatments for various...
Business / FinanceBy Rtt News2023-03-24 10:48:35
(RTTNews) - GSK PLC (GSK.L, GSK) issued a statement as response to Sargon ruling by the California state court in respect of the Goetz case. The company...
SciencePress Release2023-03-23 12:00:00
Media Release 2 nd line NSCLC patients refractory to anti-PD-(L)1 treatment have few therapeutic options, and the addition of efti to pembrolizumab may help...
Business / FinanceBy Rtt News2023-03-24 10:52:29
(RTTNews) - Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib...
HealthPress Release2023-03-24 13:00:00
First in human study will evaluate safety, tolerability, and pharmacokinetic parameters of NRL-1049, a Rho kinase (ROCK) inhibitor SAN DIEGO, Calif., March...
HealthPress Release2023-03-24 13:02:59
Ovarian Cancer Drugs Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032 The Business Research Company's Ovarian Cancer Drugs...
HealthPress Release2023-03-23 10:11:00
CAMBRIDGE, Mass., March 23, 2023 /PRNewswire/ -- ONO PHARMA USA, INC., announced that its candidate, tirabrutinib (ONO-4059), a Bruton's tyrosine kinase...
Business / FinanceBy Calum Muirhead2023-03-24 21:51:09
GlaxoSmithKline suffered a blow after a US judge ruled against it in a lawsuit relating to its heartburn drug Zantac. The FTSE 100 pharmaceuticals group and...
SciencePress Release2023-03-24 07:30:00
Signed a collaboration agreement with BioNTech to develop and commercialize immunomodulatory small molecule therapeutics; deal terms included 20M upfront...
HealthPress Release2023-03-23 10:30:00
CAMBRIDGE, Mass., March 23, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely...
SciencePress Release2023-03-23 23:59:32
LANDMARK INTERNATIONAL COLLABORATION CREATES A FOUNDATION FOR DRUG DEVELOPMENT IN YOUNG ADULT CANCER CALLED CCS, OPENING THE DOOR TO NEW POTENTIAL THERAPY...
SciencePress Release2023-03-23 21:01:00
Starting in 2023, Celyad Oncology is now entirely focused on its new business strategy with one clear objective: help to overcome the current limitations of...
HealthPress Release2023-03-24 12:54:00
LOS ANGELES, March 24, 2023 /PRNewswire/ -- Waismann Method®, a reputable addiction treatment center, is calling for urgent nationwide action to address the...
HealthPress Release2023-03-24 18:00:00
NEW YORK, March 24, 2023 /PRNewswire/ -- The non-hodgkin lymphoma therapeutics market size is forecast to grow by USD 5,427.51 million between 2022 and 2027,...
SciencePress Release2023-03-23 11:30:00
BBP-398, an investigational SHP2 inhibitor, is a potentially best-in-class therapy for use in combination approaches, which is shown by preclinical findings...
SciencePress Release2023-03-23 20:05:00
- Cleared dose-limiting toxicity (DLT) observation period with more frequent, dose-intensive regimen of CAB-AXL BA3011; anticipated leiomyosarcoma (LMS)...